Search research articles
Contact Us
Filters
Showing results (141-150 of 178) with videos related to
Page
of 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2022
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute
Dai Chihara, Erich P Huang, Shanda R Finnigan, et al.
Journal of the American College of Cardiology
|
October 4, 2005
ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 2: pediatric training guidelines for noninvasive cardiac imaging endorsed by the American Society of Echocardiography and the Society of Pediatric Echocardiography
Stephen P Sanders, Steven D Colan, Timothy M Cordes, et al.
Clinical Genitourinary Cancer
|
April 25, 2020
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment
Ravi A Madan, Keith T Schmidt, Fatima Karzai, et al.
Nature
|
February 17, 2006
Transient radio bursts from rotating neutron stars
M A McLaughlin, A G Lyne, D R Lorimer, et al.
The Oncologist
|
May 31, 2022
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide
Keith T Schmidt, Fatima Karzai, Marijo Bilusic, et al.
Cancer Immunology, Immunotherapy : CII
|
June 17, 2026
Bintrafusp alfa for patients with recurrent or metastatic olfactory neuroblastoma
Nyall R London, Dara Bracken-Clarke, Elisabetta Xue, et al.
Frontiers in Oncology
|
March 22, 2021
Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer
Margaret E Gatti-Mays, Sofia R Gameiro, Yohei Ozawa, et al.
Nature
|
July 10, 2020
Asymmetric mass ratios for bright double neutron-star mergers
R D Ferdman, P C C Freire, B B P Perera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2019
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
Margaret E Gatti-Mays, Julius Strauss, Renee N Donahue, et al.
European Urology Oncology
|
October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide
Shruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 178) with videos related to
Sort By:
Page
of 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2022
Trends in Grade 5 Toxicity and Response in Phase I Trials in Hematologic Malignancy: 20-Year Experience From the Cancer Therapy Evaluation Program at the National Cancer Institute
Dai Chihara, Erich P Huang, Shanda R Finnigan, et al.
Journal of the American College of Cardiology
|
October 4, 2005
ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 2: pediatric training guidelines for noninvasive cardiac imaging endorsed by the American Society of Echocardiography and the Society of Pediatric Echocardiography
Stephen P Sanders, Steven D Colan, Timothy M Cordes, et al.
Clinical Genitourinary Cancer
|
April 25, 2020
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment
Ravi A Madan, Keith T Schmidt, Fatima Karzai, et al.
Nature
|
February 17, 2006
Transient radio bursts from rotating neutron stars
M A McLaughlin, A G Lyne, D R Lorimer, et al.
The Oncologist
|
May 31, 2022
A Single-arm Phase II Study Combining NLG207, a Nanoparticle Camptothecin, with Enzalutamide in Advanced Metastatic Castration-resistant Prostate Cancer Post-Enzalutamide
Keith T Schmidt, Fatima Karzai, Marijo Bilusic, et al.
Cancer Immunology, Immunotherapy : CII
|
June 17, 2026
Bintrafusp alfa for patients with recurrent or metastatic olfactory neuroblastoma
Nyall R London, Dara Bracken-Clarke, Elisabetta Xue, et al.
Frontiers in Oncology
|
March 22, 2021
Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer
Margaret E Gatti-Mays, Sofia R Gameiro, Yohei Ozawa, et al.
Nature
|
July 10, 2020
Asymmetric mass ratios for bright double neutron-star mergers
R D Ferdman, P C C Freire, B B P Perera, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 22, 2019
A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
Margaret E Gatti-Mays, Julius Strauss, Renee N Donahue, et al.
European Urology Oncology
|
October 20, 2023
Quantitative Analysis of Serial Positron Emission Tomography Imaging in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide
Shruti U Gandhy, Fatima H Karzai, Marijo Bilusic, et al.
Page
of 18